EpiPen rival plans return to U.S. market in first-half 2017

(Reuters) - Privately held drugmaker Kaleo Inc announced on Wednesday plans for a U.S. relaunch of its Auvi-Q injector for life-threatening allergic reactions in the first half of next year.